Impact of clinical pharmacist-led medication management and education on tacrolimus therapeutic control
Nur Ozturk, Büşra Nur Çattık, Barış Malbora, Ayşe Burcu Akıncı, Başak Adaklı Aksoy, Dilek Ece, Tunç Fişgin, Müge Gündoğdu, Melek Erdem, Safiye Suna Çelen, Nilay Aksoy · 2026
Read Impact of clinical pharmacist-led medication management and education on tacrolimus therapeutic control by Nur Ozturk, Büşra Nur Çattık, Barış Malbora, Ayşe Burcu Akıncı, Başak Adaklı Aksoy, Dilek Ece, Tunç Fişgin, Müge Gündoğdu, Melek Erdem, Safiye Suna Çelen, Nilay Aksoy (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13286822.txt.
Description
Nur Ozturk and colleagues test whether clinical pharmacists can steady levels of tacrolimus, a transplant drug with a narrow safe range, in children after bone marrow transplant. The 2026 study ran across five Istanbul hospitals with 65 young patients, their caregivers, and 50 nurses. Pharmacists hunted for drug-related problems and taught families and nurses how to handle the medicine.
More than three quarters of the pharmacists' interventions were resolved. The share of children whose drug levels sat in range climbed from about half to over four fifths after education and stayed there three months later. Caregiver and nurse knowledge rose and held. Unresolved drug problems predicted unstable levels, which the authors say makes the pharmacist's role central.
Catalog record
| CREATOR | Nur Ozturk, Büşra Nur Çattık, Barış Malbora, Ayşe Burcu Akıncı, Başak Adaklı Aksoy, Dilek Ece, Tunç Fişgin, Müge Gündoğdu, Melek Erdem, Safiye Suna Çelen, Nilay Aksoy |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |